Cargando…
The fecal microbiome and serum concentrations of indoxyl sulfate and p‐cresol sulfate in cats with chronic kidney disease
BACKGROUND: Intestinal dysbiosis has been documented in humans with chronic kidney disease (CKD) and is thought to contribute to production of the uremic toxins indoxyl sulfate (IS) and p‐cresol sulfate (pCS). Characteristics of the fecal microbiome in cats with CKD and correlation to serum concentr...
Autores principales: | Summers, Stacie C., Quimby, Jessica M., Isaiah, Anitha, Suchodolski, Jan S., Lunghofer, Paul J., Gustafson, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430892/ https://www.ncbi.nlm.nih.gov/pubmed/30561098 http://dx.doi.org/10.1111/jvim.15389 |
Ejemplares similares
-
Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p‐cresol sulfate
por: Summers, Stacie, et al.
Publicado: (2019) -
The association of indoxyl sulfate with fibroblast growth factor‐23 in cats with chronic kidney disease
por: Liao, Yu‐Lun, et al.
Publicado: (2019) -
Biological variation of major gut‐derived uremic toxins in the serum of healthy adult cats
por: Summers, Stacie, et al.
Publicado: (2021) -
Fecal short‐chain fatty acid concentrations and dysbiosis in dogs with chronic enteropathy
por: Minamoto, Yasushi, et al.
Publicado: (2019) -
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
por: Liu, Wen-Chih, et al.
Publicado: (2018)